A randomised trial examining the effectiveness of sympathetic nervous inhibition in alleviating the metabolic side effects of antipsychotic medications in patients with schizophrenia
A randomised trial examining the effectiveness of sympathetic nervous inhibition in alleviating the metabolic side effects of antipsychotic medications in patients with schizophrenia
一项随机试验，检验交感神经抑制在减轻精神分裂症患者抗精神病药物代谢副作用方面的有效性
批准号：
nhmrc : 1022794
负责人：
Dr Nora Straznicky
金额：
$31.83万
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2012
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2012-01-01 至 2015-12-31
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite improved diagnosis and increased use of antipsychotic medications the mortality risk in patients with schizophrenia remains 2-3 times that of the general population, largely due to cardiovascular disease development. In this project we will test the effectiveness of sympathetic nervous inhibition with moxonidine (as add on therapy) in alleviating the metabolic side effects of antipsychotic medications in patients with schizophrenia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Breaking up prolonged sitting: a practical daily therapeutic tool in the management of type 2 diabetes?
-
批准号：nhmrc : 1081734
-
项目类别：Project Grants
-
资助金额：$21.24万
-
财政年份：2015
-
负责人：Dr Nora Straznicky
-
依托单位：
国内基金
海外基金
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验：The ASCVD Risk Intervention Trial
-
批准号：81973152
-
项目类别：面上项目
-
资助金额：54.0万元
-
批准年份：2019
-
负责人：胡东生
-
依托单位：
